# Safinamide Steady State Interaction With Rosuvastatin

> **NCT03216304** · PHASE1 · COMPLETED · sponsor: **Cross Research S.A.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 100 mg safinamide
- **DRUG:** 20 mg rosuvastatin calcium period 1
- **DRUG:** 20 mg rosuvastatin calcium period 2

## Key facts

- **NCT ID:** NCT03216304
- **Lead sponsor:** Cross Research S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-22
- **Primary completion:** 2017-07-06
- **Final completion:** 2017-07-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216304, "Safinamide Steady State Interaction With Rosuvastatin". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03216304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*